Cargando…
The Use of Vasoactive Drugs in the Treatment of Male Erectile Dysfunction: Current Concepts
It is widely accepted that disorders of the male (uro)genital tract, such as erectile dysfunction (ED) and benign diseases of the prostate (lower urinary tract symptomatology or benign prostatic hyperplasia), can be approached therapeutically by influencing the function of both the vascular and non-...
Autores principales: | Kedia, George T., Ückert, Stefan, Tsikas, Dimitrios, Becker, Armin J., Kuczyk, Markus A., Bannowsky, Andreas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564459/ https://www.ncbi.nlm.nih.gov/pubmed/32947804 http://dx.doi.org/10.3390/jcm9092987 |
Ejemplares similares
-
Is cortisol an endogenous mediator of erectile dysfunction in the adult male?
por: Rahardjo, Harrina E., et al.
Publicado: (2023) -
Expression of Phosphodiesterase (PDE) Isoenzymes in the Human Male and Female Urethra
por: Rahardjo, Harrina E, et al.
Publicado: (2021) -
Fibrotic Diseases of the Human Urinary and Genital Tract: Current Understanding and Potential Strategies for Treatment
por: Rahardjo, Harrina E., et al.
Publicado: (2023) -
S-Nitroso-N-acetyl-L-cysteine ethyl ester (SNACET) and N-acetyl-L-cysteine ethyl ester (NACET)–Cysteine-based drug candidates with unique pharmacological profiles for oral use as NO, H(2)S and GSH suppliers and as antioxidants: Results and overview
por: Tsikas, Dimitrios, et al.
Publicado: (2018) -
Combined intracavernous vasoactive drugs and sildenafil citrate in treatment of severe erectile dysfunction not responding to on-demand monotherapy
por: Al-Adl, Ahmed M., et al.
Publicado: (2011)